Fosfomycin Tromethamine Granule, For Solution
NDC Package 81033-024-11
Package Information
Fosfomycin Tromethamine granules is a medication an antibiotic used to treat bladder infections (such as acute cystitis or lower urinary tract infections) in women. This formulation utilizes a granule, for solution delivery system. Marketed by Kesin Pharma Corporation, this product is identified by NDC 81033-024 and is authorized under FDA application ANDA214554.
Identification & Billing
- RxCUI: 808917 - fosfomycin 3 GM Granules for Oral Solution
- RxCUI: 808917 - fosfomycin 3000 MG Granules for Oral Solution
- RxCUI: 808917 - fosfomycin (as fosfomycin tromethamine) 3000 MG Granules for Oral Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 81033 - Kesin Pharma Corporation
- 81033-024 - Fosfomycin Tromethamine
- 81033-024-11 - 1 PACKET in 1 CARTON / 1 GRANULE, FOR SOLUTION in 1 PACKET (81033-024-03)
- 81033-024 - Fosfomycin Tromethamine
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 81033-024-11 identifies a specific commercial package of 1 packet in 1 carton / 1 granule, for solution in 1 packet (81033-024-03) of Fosfomycin Tromethamine, a human prescription drug labeled by Kesin Pharma Corporation. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This granule, for solution is formulated for oral use and contains fosfomycin tromethamine as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Kesin Pharma Corporation on October 22, 2021. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is an antibiotic used to treat bladder infections (such as acute cystitis or lower urinary tract infections) in women. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. Fosfomycin should not be used to treat infections outside the bladder (such as kidney infections).
How is this Kesin Pharma Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 81033002411. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.